Maggiori informazioni sul libro
This rewritten and updated second edition provides comprehensive information on the wide-ranging applications of statistics in the pharmacological field. Focusing on practical aspects, it sets out to bridge the gap between industry and academia.;Reflecting the changes that have taken place since publication of the first edition, this volume covers new topics such as: cancer clinical trials, clinical trials of AIDS patients and animal tumorigenicity studies; the development of antiepileptic drugs; the role of epidemiology in postmarketing trials and adverse drug experience; computer-assisted new drug application (CANDA) submissions; contract research organizations; interim analysis in clinical trials; and room-temperature tests for the stability of drugs.;This work is intended as: a reference for statisticians, biostatisticians, pharmacologists, administrators, managers, and scientists in the pharmaceutical industry; and a text for graduate students taking courses in applied statistics or pharmaceutical statistics.
Acquisto del libro
Statistics: Textbooks and Monographs - 140: Statistics in the Pharmaceutical Industry, Charles Ralph Buncher, Jia-Yeong Tsay
- Lingua
- Pubblicato
- 1993
- product-detail.submit-box.info.binding
- (Copertina rigida),
- Condizioni del libro
- Danneggiato
- Prezzo
- 5,42 €
Metodi di pagamento
Ancora nessuna valutazione.
- Titolo
- Statistics: Textbooks and Monographs - 140: Statistics in the Pharmaceutical Industry
- Sottotitolo
- 3rd Edition
- Lingua
- Inglese
- Editore
- CRC Press
- Pubblicato
- 1993
- Formato
- Copertina rigida
- Pagine
- 592
- ISBN10
- 0824790731
- ISBN13
- 9780824790738
- Serie
- Tag
- Saggistica, Scienza e Matematica, USA, Matematica, Tecnologia, Medicina, Droghe, Farmacia, Farmaci, medicinali, Epidemiologia
- Descrizione
- This rewritten and updated second edition provides comprehensive information on the wide-ranging applications of statistics in the pharmacological field. Focusing on practical aspects, it sets out to bridge the gap between industry and academia.;Reflecting the changes that have taken place since publication of the first edition, this volume covers new topics such as: cancer clinical trials, clinical trials of AIDS patients and animal tumorigenicity studies; the development of antiepileptic drugs; the role of epidemiology in postmarketing trials and adverse drug experience; computer-assisted new drug application (CANDA) submissions; contract research organizations; interim analysis in clinical trials; and room-temperature tests for the stability of drugs.;This work is intended as: a reference for statisticians, biostatisticians, pharmacologists, administrators, managers, and scientists in the pharmaceutical industry; and a text for graduate students taking courses in applied statistics or pharmaceutical statistics.